Peer Review reports
From: Phase II trial of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
Original Submission | ||
---|---|---|
2 Apr 2021 | Submitted | Original manuscript |
23 May 2021 | Reviewed | Reviewer Report |
30 May 2021 | Reviewed | Reviewer Report |
8 Jun 2021 | Author responded | Author comments - Biyun Wang |
Resubmission - Version 2 | ||
8 Jun 2021 | Submitted | Manuscript version 2 |
9 Jun 2021 | Author responded | Author comments - Biyun Wang |
Resubmission - Version 3 | ||
9 Jun 2021 | Submitted | Manuscript version 3 |
15 Jun 2021 | Reviewed | Reviewer Report |
17 Jun 2021 | Reviewed | Reviewer Report |
Resubmission - Version 4 | ||
Submitted | Manuscript version 4 | |
Publishing | ||
27 Oct 2021 | Editorially accepted | |
2 Nov 2021 | Article published | 10.1186/s12885-021-08921-2 |
You can find further information about peer review here.